SCHEMBL3682459

SCHEMBL3682459

CC(=O)Cc1ccc(CS)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.52
▸ IDO1 P14902 5/20 0.48
▸ FOLH1 Q04609 2/20 0.39
▸ CA2 P00918 2/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ CAMK2A Q9UQM7 1/20 0.38
▸ ANPEP P15144 1/20 0.37
▸ ENPEP Q07075 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ CES2 O00748 1/20 0.36
▸ CES1 P23141 1/20 0.36
▸ AKR1B1 P15121 1/20 0.36
▸ ABCC4 O15439 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ PTGS1 P23219 1/20 0.35
▸ HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8403545 0.87 POLB (0.61) POLBCA2KMT2ACAMK2AALDH1A1
SCHEMBL8986864 0.81 POLB (0.52) POLBCA2KMT2ACAMK2AALDH1A1
SCHEMBL15251712 0.80 IDO1 (0.46) IDO1FOLH1CA2CAMK2AANPEP
SCHEMBL10775630 0.80 POLB (0.55) POLBCA2KMT2ACAMK2AALDH1A1
SCHEMBL8277240 0.78 CA2 (0.62) POLBCA2KMT2ACAMK2AANPEP
SCHEMBL2357364 0.78 CA2 (0.62) POLBIDO1FOLH1CA2KMT2A
SCHEMBL4455 0.78 CA2 (0.62) POLBIDO1CA2CAMK2AALDH1A1
SCHEMBL81559 0.78 CTBP2 (0.53) POLBKMT2AALDH1A1HPGDLMNA
SCHEMBL9149413 0.78 POLB (0.53) POLBCA2KMT2ACAMK2AALDH1A1
SCHEMBL5536012 0.78 POLB (0.53) POLBCA2KMT2ACAMK2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014183221-A1 RESVERATROL ANALOGS AND THERAPEUTIC USES THEREOF THE CENTRE FOR DRUG RESEARCH AND DEVELOPMENT (CA) 2014-11-20 — — WO disclosed
EP-2185621-A1 CURABLE RESIN COMPOSITION FOR MOLDED BODIES, MOLDED BODY, AND PRODUCTION METHOD THEREOF Nippon Shokubai Co., Ltd. (JP) 2010-05-19 — — EP disclosed
WO-2009041711-A1 CURABLE RESIN COMPOSITION FOR MOLDED BODIES, MOLDED BODY, AND PRODUCTION METHOD THEREOF NIPPON SHOKUBAI CO., LTD. (JP) 2009-04-02 — — WO disclosed
EP-1288206-B1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors SEARLE LLC (US) 2008-09-17 — — EP disclosed
Send feedback